Ignite Creation Date:
2024-05-05 @ 4:40 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00291850
Status:
TERMINATED
Last Update Posted:
2012-05-01
First Post:
2006-02-14
Brief Title:
Phase II Trial of Dose-dense Paclitaxel and Cisplatin as Neo-adjuvant Chemotherapy for Operable Stage II and IIA NSCLC
Sponsor:
Central European Cooperative Oncology Group
Organization:
Central European Cooperative Oncology Group
Organization Data
Organization:
Central European Cooperative Oncology Group
Class:
OTHER
Study ID:
CECOGNSCLC32002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Central European Cooperative Oncology Group
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None